Innovative Pharmaceutical Biotech's total assets for Q4 2023 were HK$1.38B, an increase of 0.06% from the previous quarter. HK:0399 total liabilities were HK$1.06B for the fiscal quarter, a 1.38% a decrease from the previous quarter. See a summary of the company’s assets, liabilities, and equity.